12- and 15-lipoxygenases in human carotid atherosclerotic lesions: Associations with cerebrovascular symptoms

Atherosclerosis

Volumn 215, Issue 2, 2011, Pages 411-416

  Gertow, Karl ^a   Nobili, Elena ^b,c   Folkersen, Lasse ^a   Newman, John W ^d   Pedersen, Theresa L ^d   Ekstrand, Johan ^a   Swedenborg, Jesper ^a   Kühn, Hartmut ^e   Wheelock, Craig E ^a   Hansson, Göran K ^a   Hedin, Ulf ^a   Haeggström, Jesper Z ^a   Gabrielsen, Anders ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF MILAN   (Italy)

^c CENTRO CARDIOLOGICO MONZINO   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Carotid atherosclerosis; Eicosanoid; Endarterectomy; Lipoxygenase; MRNA; Stroke

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 12B LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 15B LIPOXYGENASE; ARACHIDONATE E3 LIPOXYGENASE; LIPOXYGENASE; MESSENGER RNA; OXYLIPIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID ANALYSIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA HYBRIDIZATION; STROKE; TRANSIENT ISCHEMIC ATTACK; TRANSITIONAL BLINDNESS;

AGED; AMAUROSIS FUGAX; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; ATHEROSCLEROSIS; CAROTID STENOSIS; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; PLAQUE, ATHEROSCLEROTIC; RNA, MESSENGER; STROKE;

EID: 79953047839     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.01.015     Document Type: Article

References (30)

1. Back M. Leukotriene signaling in atherosclerosis and ischemia. Cardiovasc Drugs Ther 2009, 23:41-48.
2. Kuhn H. Biologic relevance of lipoxygenase isoforms in atherogenesis. Expert Rev Cardiovasc Ther 2005, 3:1099-1110.
3. Kuhn H., O'Donnell V.B. Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res 2006, 45:334-356.
4. Wittwer J., Hersberger M. The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 2007, 77:67-77.
5. Yu Z., Schneider C., Boeglin W.E., Marnett L.J., Brash A.R. The lipoxygenase gene ALOXE3 implicated in skin differentiation encodes a hydroperoxide isomerase. Proc Natl Acad Sci USA 2003, 100:9162-9167.
6. Haeggstrom J.Z., Wetterholm A. Enzymes and receptors in the leukotriene cascade. Cell Mol Life Sci 2002, 59:742-753.
7. Whatling C., McPheat W., Herslof M. The potential link between atherosclerosis and the 5-lipoxygenase pathway: investigational agents with new implications for the cardiovascular field. Expert Opin Investig Drugs 2007, 16:1879-1893.
8. Hulten L.M., Olson F.J., Aberg H., et al. 15-Lipoxygenase-2 is expressed in macrophages in human carotid plaques and regulated by hypoxia-inducible factor-1alpha. Eur J Clin Invest 2009, 40:11-17.
9. Rydberg E.K., Krettek A., Ullstrom C., et al. Hypoxia increases LDL oxidation and expression of 15-lipoxygenase-2 in human macrophages. Arterioscler Thromb Vasc Biol 2004, 24:2040-2045.
10. Qiu H., Gabrielsen A., Agardh H.E., et al. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci USA 2006, 103:8161-8166.
11. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
12. Vandesompele J., De Preter K., Pattyn F., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3. RESEARCH0034.
13. Irizarry R.A., Hobbs B., Collin F., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
14. Luria A., Weldon S.M., Kabcenell A.K., et al. Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice. J Biol Chem 2007, 282:2891-2898.
15. Shearer G.C., Harris W.S., Pedersen T.L., Newman J.W. Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters. J Lipid Res 2010, 51:2074-2081.
16. Spanbroek R., Grabner R., Lotzer K., et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci USA 2003, 100:1238-1243.
17. Yla-Herttuala S., Rosenfeld M.E., Parthasarathy S., et al. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci USA 1990, 87:6959-6963.
18. Peeters W., Hellings W.E., de Kleijn D.P., et al. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler Thromb Vasc Biol 2009, 29:128-133.
19. Brash A.R., Boeglin W.E., Chang M.S. Discovery of a second 15S-lipoxygenase in humans. Proc Natl Acad Sci USA 1997, 94:6148-6152.
20. Kilty I., Logan A., Vickers P.J. Differential characteristics of human 15-lipoxygenase isozymes and a novel splice variant of 15S-lipoxygenase. Eur J Biochem 1999, 266:83-93.
21. Tang D.G., Bhatia B., Tang S., Schneider-Broussard R. 15-lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size). Prostaglandins Other Lipid Mediat 2007, 82:135-146.
22. Tang S., Bhatia B., Maldonado C.J., et al. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. J Biol Chem 2002, 277:16189-16201.
23. Cai Q., Lanting L., Natarajan R. Growth factors induce monocyte binding to vascular smooth muscle cells: implications for monocyte retention in atherosclerosis. Am J Physiol Cell Physiol 2004, 287:C707-C714.
24. Huang J.T., Welch J.S., Ricote M., et al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999, 400:378-382.
25. Patricia M.K., Kim J.A., Harper C.M., et al. Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells. Arterioscler Thromb Vasc Biol 1999, 19:2615-2622.
26. Smith R.J., Justen J.M., Nidy E.G., Sam L.M., Bleasdale J.E. Transmembrane signaling in human polymorphonuclear neutrophils: 15(S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid modulates receptor agonist-triggered cell activation. Proc Natl Acad Sci USA 1993, 90:7270-7274.
27. Takata S., Matsubara M., Allen P.G., Janmey P.A., Serhan C.N., Brady H.R. Remodeling of neutrophil phospholipids with 15(S)-hydroxyeicosatetraenoic acid inhibits leukotriene B4-induced neutrophil migration across endothelium. J Clin Invest 1994, 93:499-508.
28. Takata S., Papayianni A., Matsubara M., Jimenez W., Pronovost P.H., Brady H.R. 15-Hydroxyeicosatetraenoic acid inhibits neutrophil migration across cytokine-activated endothelium. Am J Pathol 1994, 145:541-549.
29. Mallat Z., Nakamura T., Ohan J., et al. The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis. J Clin Invest 1999, 103:421-427.
30. Waddington E.I., Croft K.D., Sienuarine K., Latham B., Puddey I.B. Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates. Atherosclerosis 2003, 167:111-120.